The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Initial results from a multicenter study (LCMC3).
 
Valerie W. Rusch
Research Funding - Genelux (Inst)
Travel, Accommodations, Expenses - da Vinci Surgery
Other Relationship - Bristol-Myers Squibb
 
Jamie E. Chaft
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Merck
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
 
Bruce Johnson
Consulting or Advisory Role - KEW
Research Funding - Genentech/Roche; Novartis; Toshiba
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - Ariad; AstraZeneca/MedImmune; Asuragen; Bristol-Myers Squibb; Genentech/Roche; HTG Molecular Diagnostics; Lilly; Pfizer
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer
Research Funding - Adaptimmune; EMD Serono; Genentech; HTG Molecular Diagnostics; MedImmune; Merck; Myriad Genetics; OncoPlex Diagnostics; Pfizer; Silicon Biosytems
 
Mark G. Kris
Consulting or Advisory Role - AstraZeneca
 
Jay M. Lee
Travel, Accommodations, Expenses - Genentech/Roche
 
Paul A. Bunn
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; Merck Serono; Novartis
Research Funding - Genentech (Inst)
 
David J. Kwiatkowski
Consulting or Advisory Role - AstraZeneca; Genentech/Roche
Research Funding - AADi
 
Karen L. Reckamp
Consulting or Advisory Role - Amgen; ARIAD; Astellas Pharma; Boehringer Ingelheim; Euclises; Takeda; Tesaro
Research Funding - Abbvie; Adaptimmune (Inst); ARIAD (Inst); Boehringer Ingelheim; Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Xcovery (Inst)
 
David J Finley
No Relationships to Disclose
 
Eric B. Haura
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen Oncology
Research Funding - Boehringer Ingelheim; FORMA Therapeutics; Ignyta; Janssen; Lilly
Patents, Royalties, Other Intellectual Property - Patent pending on PLA technology related to kinase inhibitor sensitivity biomarkers
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Saiama Naheed Waqar
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Checkpoint Therapeutics (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Hengrui Therapeutics (Inst); Ignyta (Inst); Lilly (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Spectrum Pharmaceuticals (Inst); Stem CentRx (Inst); Synermore biologics (Inst); Vertex (Inst); Xcovery (Inst)
 
Robert Charles Doebele
Stock and Other Ownership Interests - Rain Therapeutics
Honoraria - ARIAD; AstraZeneca; Guardant Health; Pfizer; Spectrum Pharmaceuticals; Takeda; Trovagene
Consulting or Advisory Role - AstraZeneca; GreenPeptide; Ignyta; OncoMed; Pfizer; Trovagene
Research Funding - Ignyta (Inst)
Patents, Royalties, Other Intellectual Property - Licensing Fees from Abbott Molecular for Patent PCT/US2013/057495; Licensing fees from Ignyta for biologic materials (Inst)
Travel, Accommodations, Expenses - ARIAD; Guardant Health; Ignyta
 
Edward B. Garon
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst)
 
Justin Blasberg
No Relationships to Disclose
 
Alan Nicholas
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Katja Schulze
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
See-Chun Phan
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Mayank Gandhi
Employment - Genentech
Stock and Other Ownership Interests - Acadia Pharmaceuticals; Celgene; Merck; Neurocrine Biosciences; Roche; Spark Therapeutics
 
David Paul Carbone
Consulting or Advisory Role - Genentech
Research Funding - Bristol-Myers Squibb